Earnings Call · Q2 FY2026·2026-07-30

Q2 26EPS +25.53%·Rev n/aQ1 26EPS +14.12%·Rev n/aQ4 25EPS -18.26%·Rev n/aQ3 25EPS +4.83%·Rev n/a⚠ consensus missing

NEUROCRINE BIOSCIENCES INC NBIX

Todd Tushla — Vice President, Investor Relations

Kyle Gano — Chief Executive Officer

Matt Abernethy — Chief Financial Officer

Eric Benevich — Chief Commercial Officer

Sanjay Keswani — Chief Medical Officer

−10.1%1d on move date

Research tier

Behavioral profile computed for 5 speakers on this call.

Sign in to view the Behavioral Lean, the Behavioral Deviation Score, the speaker decomposition, and the novel forward-guidance phrases flagged on this call — each scored against the speaker's own prior-call baseline.

Behavioral data on every earnings call

Per-speaker language deviation, scored against each executive's own history. Explore more NBIX calls or request research access.

More NBIX calls Browse calls Request research access